{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:03:13Z","timestamp":1793775793906,"version":"4.6.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DA033934"],"award-info":[{"award-number":["P30 DA033934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA007927"],"award-info":[{"award-number":["T32DA007927"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016059"],"award-info":[{"award-number":["P30CA016059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DA0339324"],"award-info":[{"award-number":["P30DA0339324"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30385-8","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:55:51Z","timestamp":1765209351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Butyrate prevents chemotherapy-induced gastrointestinal toxicity and microbial dysbiosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Stanley M.","family":"Cheatham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayd","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Arastonejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Luffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna M.","family":"Tyc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Gewirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid I.","family":"Akbarali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"30385_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1758834009355164","volume":"2","author":"A Stein","year":"2010","unstructured":"Stein, A., Voigt, W. & Jordan, K. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther. Adv. Med. Oncol. 2, 51\u201363 (2010).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"30385_CR2","doi-asserted-by":"crossref","unstructured":"Akbarali, H. I., Muchhala, K. H., Jessup, D. K. & Cheatham, S. Chemotherapy induced gastrointestinal toxicities. Adv. Cancer Res. 155 ,131-166 (2022)","DOI":"10.1016\/bs.acr.2022.02.007"},{"key":"30385_CR3","doi-asserted-by":"crossref","unstructured":"Saliba, F. et al. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: A prospective assessment. J. Clin. Oncol. 16 ,2745-2751 (1998)","DOI":"10.1200\/JCO.1998.16.8.2745"},{"key":"30385_CR4","doi-asserted-by":"crossref","unstructured":"Stein, Alexander, Wieland Voigt, and Karin Jordan. \"Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.\" Therapeutic advances in medical oncology 2.1,  51-63 (2010)","DOI":"10.1177\/1758834009355164"},{"key":"30385_CR5","doi-asserted-by":"crossref","unstructured":"Abigerges, D. et al. Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea. J. Natl. Cancer Inst. 86.6, 446-449 (1994)","DOI":"10.1093\/jnci\/86.6.446"},{"key":"30385_CR6","doi-asserted-by":"crossref","unstructured":"Zidan, J. et al. Octreotide in the treatment of severe chemotherapy-induced diarrhea. Ann. Oncol. 12.2, 227-230 (2001)","DOI":"10.1023\/A:1008372228462"},{"key":"30385_CR7","doi-asserted-by":"crossref","unstructured":"Topkan, E. & Karaoglu, A. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. Oncology 71.5-6, 354-360 (2007)","DOI":"10.1159\/000108593"},{"key":"30385_CR8","unstructured":"Ustaris, F. et al. Effective management and prevention of neratinib-induced diarrhea. Am. J. Hematol. \/ Oncol.\u00ae 11 (2015)."},{"key":"30385_CR9","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1200\/JCO.2004.04.132","volume":"22","author":"ABB Iam","year":"2004","unstructured":"Iam, A. B. B. et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J. Clin. Oncol. 22, 2918\u20132926 (2004).","journal-title":"J. Clin. Oncol."},{"key":"30385_CR10","doi-asserted-by":"crossref","unstructured":"Maroun, J. A. et al. Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: A consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea. Curr. Oncol. 14.1, 13-20 (2007)","DOI":"10.3747\/co.2007.96"},{"key":"30385_CR11","doi-asserted-by":"crossref","unstructured":"Parvez, M. M. et al. Quantitative investigation of Irinotecan metabolism, transport, and gut microbiome activation. Drug Metab. Disposit. 49.8, 683-693 (2021)","DOI":"10.1124\/dmd.121.000476"},{"key":"30385_CR12","doi-asserted-by":"crossref","unstructured":"Stringer, A. M. et al. Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced Gastrointestinal mucositis. Exp. Biol. Med 234.4, 430-441 (2009)","DOI":"10.3181\/0810-RM-301"},{"key":"30385_CR13","doi-asserted-by":"crossref","unstructured":"McQuade, R. M. et al. irinotecan-induced gastrointestinal dysfunction is associated with enteric neuropathy, but increased numbers of cholinergic myenteric neurons. Front. Physiol. 8, 391 (2017)","DOI":"10.3389\/fphys.2017.00391"},{"key":"30385_CR14","doi-asserted-by":"crossref","unstructured":"Geng, H. W., Yin, F. Y., Zhang, Z. F., Gong, X. & Yang, Y. Butyrate suppresses glucose metabolism of colorectal cancer cells via GPR109a-AKT signaling pathway and enhances chemotherapy. Front. Mol. Biosci. 8, 634874 (2021)","DOI":"10.3389\/fmolb.2021.634874"},{"key":"30385_CR15","doi-asserted-by":"crossref","unstructured":"Shuwen, H. et al. Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer. Transl .Oncol. 27,101598 (2023)","DOI":"10.1016\/j.tranon.2022.101598"},{"key":"30385_CR16","doi-asserted-by":"crossref","unstructured":"Kleuskens, M. T. A. et al. Butyrate and propionate restore Interleukin 13-compromised esophageal epithelial barrier function. Allergy Eur. J. Allergy Clin. Immunol. 77.5, 1510-1521.(2022)","DOI":"10.1111\/all.15069"},{"key":"30385_CR17","doi-asserted-by":"crossref","unstructured":"Huang, X., Oshima, T., Tomita, T., Fukui, H. & Miwa, H. Butyrate alleviates cytokine-induced barrier dysfunction by modifying claudin-2 levels. Biology (Basel) 10.3, 205 (2021):","DOI":"10.3390\/biology10030205"},{"key":"30385_CR18","doi-asserted-by":"crossref","unstructured":"Routy, Bertrand, et al. \"Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors.\" Science 359.6371, 91-97 (2018)","DOI":"10.1126\/science.aan3706"},{"key":"30385_CR19","doi-asserted-by":"publisher","unstructured":"Chrysostomou, D., Roberts, L. A., Marchesi, J. R. & Kinross, J. M. Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy. Gastroenterology 164.2, 198-213   https:\/\/doi.org\/10.1053\/j.gastro.2022.10.018 (preprint) (2023).","DOI":"10.1053\/j.gastro.2022.10.018"},{"key":"30385_CR20","doi-asserted-by":"publisher","unstructured":"Hou, Y., Li, J. & Ying, S. Tryptophan metabolism and gut microbiota: A novel regulatory axis integrating the microbiome, immunity, and cancer. Metabolites 13.11, 1166  https:\/\/doi.org\/10.3390\/metabo13111166 (2023).","DOI":"10.3390\/metabo13111166"},{"key":"30385_CR21","doi-asserted-by":"publisher","unstructured":"O\u2019Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G. & Cryan, J. F. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 277, 32-48  https:\/\/doi.org\/10.1016\/j.bbr.2014.07.027 (2015).","DOI":"10.1016\/j.bbr.2014.07.027"},{"key":"30385_CR22","doi-asserted-by":"crossref","unstructured":"Dashnyam, P. et al. \u03b2-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut. Sci. Rep. 8.1, 16372 (2018)","DOI":"10.1038\/s41598-018-34678-z"},{"key":"30385_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00280-016-3139-y","volume":"78","author":"RA Ribeiro","year":"2016","unstructured":"Ribeiro, R. A. et al. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Cancer Chemother. Pharmacol. 78, 881\u2013893 (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"30385_CR24","doi-asserted-by":"crossref","unstructured":"Yue, S. J. et al. Total flavonoids of glycyrrhiza uralensis alleviates Irinotecan-Induced colitis via modification of gut microbiota and fecal metabolism. Front. Immunol. 12, 628358 (2021)","DOI":"10.3389\/fimmu.2021.628358"},{"key":"30385_CR25","doi-asserted-by":"crossref","unstructured":"Wang, R. et al. Flavonoids derived from liquorice suppress murine macrophage activation by up-regulating Heme oxygenase-1 independent of Nrf2 activation. Int. Immunopharmacol. 28.2, 917-924 (2015).","DOI":"10.1016\/j.intimp.2015.03.040"},{"key":"30385_CR26","first-page":"Preprintathttps","volume":"18","author":"N du Sert","year":"2020","unstructured":"du Sert, N. et al. (ed, P.) Reporting animal research: explanation and elaboration for the arrive guidelines 2.0. PLoS Biol. 18, (2020).\u00a0","journal-title":"PLoS Biol."},{"key":"30385_CR27","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/jnci\/87.24.1876","volume":"87","author":"N Ikuno","year":"1995","unstructured":"Ikuno, N., Soda, H., Watanabe, M. & Oka, M. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. JNCI: J. Natl. Cancer Inst. 87, 1876\u20131883 (1995).","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"30385_CR28","doi-asserted-by":"publisher","first-page":"e23603","DOI":"10.1096\/fj.202301590RR","volume":"38","author":"KH Muchhala","year":"2024","unstructured":"Muchhala, K. H. et al. The role of morphine-and fentanyl\u2010induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota\u2010gut\u2010brain axis. FASEB J. 38, e23603 (2024).","journal-title":"FASEB J."},{"key":"30385_CR29","doi-asserted-by":"crossref","unstructured":"Jessup, D., Woods, K., Thakker, S., Damaj, M. I. & Akbarali, H. I. Short-chain fatty acid, butyrate prevents morphine-and paclitaxel-induced nociceptive hypersensitivity. Sci. Rep. 13.1, 17805 (2023).","DOI":"10.1038\/s41598-023-44857-2"},{"key":"30385_CR30","doi-asserted-by":"crossref","unstructured":"Guabiraba, R. et al. IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice. Mucosal Immunol. 7.5, 1079-1093 (2014).","DOI":"10.1038\/mi.2013.124"},{"key":"30385_CR31","doi-asserted-by":"crossref","unstructured":"Negus, S. S. et al. Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice. Front. Pain Res. 4, 1281698 (2023)","DOI":"10.3389\/fpain.2023.1281698"},{"key":"30385_CR32","doi-asserted-by":"crossref","unstructured":"Guedia, J. et al. HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system. Sci. Rep. 6.1, 31203 (2016)","DOI":"10.1038\/srep31203"},{"key":"30385_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep42658","author":"M Kang","year":"2017","unstructured":"Kang, M., Mischel, R., Bhave, S. et al. The effect of gut microbiome on tolerance to morphine mediated antinociception in mice. Sci Rep 7, 42658.https:\/\/doi.org\/10.1038\/srep42658 (2017).","journal-title":"Sci. Rep."},{"key":"30385_CR34","doi-asserted-by":"crossref","unstructured":"Smith, T. H., Ngwainmbi, J., Grider, J. R., Dewey, W. L. & Akbarali, H. I. An in-vitro Preparation of isolated enteric neurons and glia from the myenteric plexus of the adult mouse. J. Vis. Exp. 50688 (2013)","DOI":"10.3791\/50688"},{"key":"30385_CR35","doi-asserted-by":"publisher","unstructured":"Smith TH, Grider JR, Dewey WL, Akbarali HI Morphine Decreases Enteric Neuron Excitability via Inhibition of Sodium Channels. PLOS ONE 7.9, e45251.https:\/\/doi.org\/10.1371\/journal.pone.0045251 (2012).","DOI":"10.1371\/journal.pone.0045251"},{"key":"30385_CR36","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/jpet.116.233304","volume":"357","author":"AR Gade","year":"2016","unstructured":"Gade, A. R. et al. Enhanced sensitivity of \u03b13\u03b24 nicotinic receptors in enteric neurons after long-term morphine: implication for opioid-induced constipation. J. Pharmacol. Exp. Ther. 357, 520\u2013528 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"30385_CR37","doi-asserted-by":"crossref","unstructured":"Korsten, S. G. P. J., Vromans, H., Garssen, J. & Willemsen, L. E. M. Butyrate protects barrier integrity and suppresses immune activation in a Caco-2\/PBMC co-culture model while HDAC inhibition mimics butyrate in restoring cytokine-induced barrier disruption. Nutrients 15.12, 2760 (2023)","DOI":"10.3390\/nu15122760"},{"key":"30385_CR38","doi-asserted-by":"publisher","unstructured":"Knudsen, K. E. B. et al. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients 10.10, 1499 https:\/\/doi.org\/10.3390\/nu10101499 (2018).","DOI":"10.3390\/nu10101499"},{"key":"30385_CR39","doi-asserted-by":"crossref","unstructured":"Yu, H., Wu, L. H., Xu, Z. L., Dong, D. & He, S. A. Protective effect of anthocyanins extract from blueberry on TNBS-induced IBD model of mice. Evid.-Based Complem. Altern. Med. 2011.1, 525462 (2011).","DOI":"10.1093\/ecam\/neq040"},{"key":"30385_CR40","doi-asserted-by":"crossref","unstructured":"Wong, K. K. L., Tang, L. C. Y., Zhou, J. & Ho, V. Analysis of Spatiotemporal pattern and quantification of gastrointestinal slow waves caused by anticholinergic drugs. Organogenesis 13.2, 39-62 (2017).","DOI":"10.1080\/15476278.2017.1295904"},{"key":"30385_CR41","doi-asserted-by":"crossref","unstructured":"Peng, L., He, Z., Chen, W., Holzman, I. R. & Lin, J. Effects of butyrate on intestinal barrier function in a caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 61.1, 37-41 (2007).","DOI":"10.1203\/01.pdr.0000250014.92242.f3"},{"key":"30385_CR42","doi-asserted-by":"publisher","DOI":"10.3791\/56960","author":"DR Hill","year":"2017","unstructured":"Hill, D. R., Huang, S., Tsai, Y. H., Spence, J. R. & Young, V. B. Real-time measurement of epithelial barrier permeability in human intestinal organoids.\u00a0J. Visualized Experiments. https:\/\/doi.org\/10.3791\/56960\u00a0(2017).","journal-title":"J. Visualized Experiments"},{"key":"30385_CR43","doi-asserted-by":"publisher","unstructured":"Chamseddine, A. N. et al. Intestinal bacterial \u03b2-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. Pharmacol. Ther. 199, 1-15 (2019) https:\/\/doi.org\/10.1016\/j.pharmthera.2019.03.002 (2019).","DOI":"10.1016\/j.pharmthera.2019.03.002"},{"key":"30385_CR44","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1073\/pnas.1918095117","volume":"117","author":"AP Bhatt","year":"2020","unstructured":"Bhatt, A. P. et al. Targeted Inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy. Proc. Natl. Acad. Sci. U S A. 117, 7374\u20137381 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"30385_CR45","doi-asserted-by":"crossref","unstructured":"Sun, R. et al. Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt. Toxicol. Appl. Pharmacol. 398,115032 (2020)","DOI":"10.1016\/j.taap.2020.115032"},{"key":"30385_CR46","doi-asserted-by":"publisher","unstructured":"Derrien, M., Belzer, C. & de Vos, W. M. Akkermansia muciniphila and its role in regulating host functions. Microb. Pathogen. 106, 171-181. https:\/\/doi.org\/10.1016\/j.micpath.2016.02.005 (2017).","DOI":"10.1016\/j.micpath.2016.02.005"},{"key":"30385_CR47","doi-asserted-by":"publisher","unstructured":"Zheng, M. et al. The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives. Front. Immunol. 13, 1089600 https:\/\/doi.org\/10.3389\/fimmu.2022.1089600 (2023).","DOI":"10.3389\/fimmu.2022.1089600"},{"key":"30385_CR48","doi-asserted-by":"publisher","unstructured":"Rodrigues, V. F. et al. Akkermansia muciniphila and gut immune system: A good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Front. Immunol. 13, 934695 https:\/\/doi.org\/10.3389\/fimmu.2022.934695 (2022).","DOI":"10.3389\/fimmu.2022.934695"},{"key":"30385_CR49","doi-asserted-by":"crossref","unstructured":"Donohoe, D. R. et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48.8, 612-626 (2012).","DOI":"10.1016\/j.molcel.2012.08.033"},{"key":"30385_CR50","doi-asserted-by":"crossref","unstructured":"Gibson, R. J., Bowen, J. M., Inglis, M. R. B., Cummins, A. G. & Keefe, D. M. K. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J. Gastroenterol. Hepatol. (Australia) 18.9, 1095-1100 (2003).","DOI":"10.1046\/j.1440-1746.2003.03136.x"},{"key":"30385_CR51","doi-asserted-by":"publisher","unstructured":"Harrington, A. M., Hutson, J. M. & Southwell, B. R. Cholinergic neurotransmission and muscarinic receptors in the enteric nervous system. Progr. Histochem. Cytochem. 44.4, 173-202.  https:\/\/doi.org\/10.1016\/j.proghi.2009.10.001 (2010).","DOI":"10.1016\/j.proghi.2009.10.001"},{"key":"30385_CR52","doi-asserted-by":"crossref","unstructured":"Hoffman, J. M., Mcknight, N. D., Sharkey, K. A. & Mawe, G. M. The relationship between inflammation-induced neuronal excitability and disrupted motor activity in the Guinea pig distal colon. Neurogastroenterol. Motil. 23.7, 673-e279 (2011).","DOI":"10.1111\/j.1365-2982.2011.01702.x"},{"key":"30385_CR53","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1124\/jpet.119.256941","volume":"370","author":"E Komla","year":"2019","unstructured":"Komla, E. et al. Experimental colitis enhances the rate of antinociceptive tolerance to morphine via peripheral opioid receptors. J. Pharmacol. Exp. Ther. 370, 504\u2013513 (2019).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"30385_CR54","doi-asserted-by":"crossref","unstructured":"Meng, J. et al. Opioid-induced microbial dysbiosis disrupts Irinotecan (CPT-11) metabolism and increases Gastrointestinal toxicity in a murine model. Br. J. Pharmacol. 180.10, 1362-1378 (2023)","DOI":"10.1111\/bph.16020"},{"key":"30385_CR55","doi-asserted-by":"crossref","unstructured":"Stringer, A. M. et al. Faecal microflora and \u03b2-glucuronidase expression are altered in an irinotecan-induced diarrhoea model in rats. Cancer Biol. Ther. 7.12, 1919-1925 (2008)","DOI":"10.4161\/cbt.7.12.6940"},{"key":"30385_CR56","doi-asserted-by":"crossref","unstructured":"Yue, B. et al. Berberine improves Irinotecan-Induced intestinal mucositis without impairing the Anti-colorectal cancer efficacy of Irinotecan by inhibiting bacterial \u03b2-glucuronidase. Front. Pharmacol. 12, 774560 (2021)","DOI":"10.3389\/fphar.2021.774560"},{"key":"30385_CR57","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","volume":"330","author":"BD Wallace","year":"2010","unstructured":"Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831\u2013835 (2010).","journal-title":"Science"},{"key":"30385_CR58","doi-asserted-by":"crossref","unstructured":"Bian, X. et al. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front. Microbiol. 10, 2259 (2019)","DOI":"10.3389\/fmicb.2019.02259"},{"key":"30385_CR59","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Strain-specific effects of Akkermansia muciniphila on the regulation of intestinal barrier. Food Sci. Hum. Welln. 12.5, 1526-1537 (2023)","DOI":"10.1016\/j.fshw.2023.02.022"},{"key":"30385_CR60","doi-asserted-by":"crossref","unstructured":"Nie, Y. et al. Desulfovibrio fairfieldensis-derived outer membrane vesicles damage epithelial barrier and induce inflammation and pyroptosis in macrophages. Cells 12.1, 89 (2023).","DOI":"10.3390\/cells12010089"},{"key":"30385_CR61","doi-asserted-by":"crossref","unstructured":"Earley, H. et al. A preliminary study examining the binding capacity of Akkermansia muciniphila and desulfovibrio spp., to colonic mucin in health and ulcerative colitis. PLoS One 10.10 , e0135280 (2015).","DOI":"10.1371\/journal.pone.0135280"},{"key":"30385_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13099-024-00632-w","volume":"16","author":"G Huang","year":"2024","unstructured":"Huang, G. et al. Desulfovibrio vulgaris caused gut inflammation and aggravated DSS-induced colitis in C57BL\/6 mice model. Gut Pathog. 16, 39 (2024).","journal-title":"Gut Pathog"},{"key":"30385_CR63","doi-asserted-by":"publisher","unstructured":"Liu, H. et al. Butyrate: A double-edged sword for health? Adv. Nutri. 9.1, 21.29 (2018) https:\/\/doi.org\/10.1093\/advances\/nmx009","DOI":"10.1093\/advances\/nmx009"},{"key":"30385_CR64","doi-asserted-by":"publisher","unstructured":"Hongyu Xue, Michael B. Sawyer, Catherine J. Field, Levinus A. Dieleman, Vickie E. Baracos; Nutritional Modulation of Antitumor Efficacy and Diarrhea Toxicity Related to Irinotecan Chemotherapy in Rats Bearing the Ward Colon Tumor. Clin Cancer Res 23,  7146\u20137154.https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0823 (2007).","DOI":"10.1158\/1078-0432.CCR-07-0823"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30385-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:26:31Z","timestamp":1767788791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30385-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30385"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30385-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"785"}}